Opportunistic Infections  Citation List: 

April 15, 2009 – April 28, 2009

Opportunistic protozoa (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma]) 

1. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.

de Oliveira TS, Oliveira Silva DA, Rostkowska C, Béla SR, Ferro EA, Magalhães PM, Mineo JR.

Exp Parasitol. 2009 Apr 20. [Epub ahead of print]

PMID: 19389400 [PubMed - as supplied by publisher]

2. Thioureides of 2-(phenoxymethyl)benzoic acid 4-R substituted: A novel class of anti-parasitic compounds.

Müller J, Limban C, Stadelmann B, Missir AV, Chirita IC, Chifiriuc MC, Nitulescu GM, Hemphill A.

Parasitol Int. 2009 Jun;58(2):128-35. Epub 2008 Dec 25.

PMID: 19162220 [PubMed - in process]

Opportunistic Fungi (Cryptococcus, Aspergillus, Candida, Histoplasma)

3. Hybrid molecules between benzenesulfonamides and active antimicrobial benzo[d]isothiazol-3-ones.

Zani F, Incerti M, Ferretti R, Vicini P.

Eur J Med Chem. 2009 Jun;44(6):2741-7. Epub 2008 Jul 25.

PMID: 18775586 [PubMed - in process]

4. Differential expression of Aspergillus fumigatus protein in response to treatment with a novel antifungal compound, diethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarboxylate.

Chhillar AK, Yadav V, Kumar A, Kumar M, Parmar VS, Prasad A, Sharma GL.

Mycoses. 2009 May;52(3):223-7. Epub 2008 Sep 12.

PMID: 18793265 [PubMed - in process]

5. Growth inhibition and ultrastructural alterations induced by Delta24(25)-sterol methyltransferase inhibitors in Candida spp. isolates, including non-albicans organisms.

Ishida K, Cola Fernandes Rodrigues J, Dornelas Ribeiro M, Vila TV, de Souza W, Urbina JA, Nakamura CV, Rozental S.

BMC Microbiol. 2009 Apr 20;9(1):74. [Epub ahead of print]

PMID: 19379501 [PubMed - as supplied by publisher]

TB (Tuberculosis, Mycobacterium, Avium, Drug Resistant, MAC, MDR)

6. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.

Kurth F, Pongratz P, Belard S, Mordmuller B, Kremsner PG, Ramharter M.

Malar J. 2009 Apr 23;8(1):79. [Epub ahead of print]

PMID: 19389221 [PubMed - as supplied by publisher]

Antimicrobials, Antifungals (General)

7. The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target.

Mazumdar K, Dastidar SG, Park JH, Dutta NK.

Eur J Clin Microbiol Infect Dis. 2009 Apr 28. [Epub ahead of print]

PMID: 19399540 [PubMed - as supplied by publisher]

8. Comparing anti-HIV, antibacterial, antifungal, micellar, and cytotoxic properties of tricarboxylato dendritic amphiphiles.

Macri RV, Karlovská J, Doncel GF, Du X, Maisuria BB, Williams AA, Sugandhi EW, Falkinham JO 3rd, Esker AR, Gandour RD.

Bioorg Med Chem. 2009 Apr 15;17(8):3162-8. Epub 2009 Mar 5.

PMID: 19307123 [PubMed - in process]

Citations from the ISI Web of  Knowledge Listings for  O.I.

9. Wang, Y.L., et al.

Purification and characterization of novel antifungal peptide, mouse beta defensin-1, in Escherichia coli

WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY  2009 (May) 25:  917 – 920

Citations from the SciFinder Listings for  O.I.

10. Demirci, Betuel; Toyota, Masao; Demirci, Fatih; Dadandi, Mehmet Y.; Can Baser, K. Huesnue.

Anticandidal pimaradiene diterpene from Phlomis essential oils.

Comptes Rendus Chimie  (2009),  12(5),  612-621

11. Rokad SV, Tala SD, Akbari JD, Dhaduk MF, Joshi HS. Synthesis, antitubercular and antimicrobial activity of some new N-aryl-1,4-dihydropyridines containing furan nucleus. Journal of the Indian Chemical Society  (2009),  86(2),  186-191.